Triple negative breast cancer patients are given new hope

Kay Kingham (left), 52, from North-East London, was diagnosed with triple negative breast cancer in 2018. Three months after enrolling on a clinical trial of pembrolizumab, she had little trace of the disease.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news